Wed, Jul 23, 2014, 3:35 AM EDT - U.S. Markets open in 5 hrs 55 mins

Recent

% | $
Click the to save as a favorite.

IntelliCell BioSciences, Inc. Message Board

athec_99 182 posts  |  Last Activity: 16 hours ago Member since: Feb 24, 2014
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • athec_99 athec_99 16 hours ago Flag

    Glad you asked! Because all this money is going to pay for a court ordered amount where Dr. B had to admit guilt by way of a Judgement of Confession to the claim and repay the US Small Business Administration (as receiver for Trident Growth Fund LP) $1.3 million. He and Victor Cosmeceuticals were the defendants. So again, we have SVFC shareholders paying the price for Dr. B's past transgressions.

    Sentiment: Strong Sell

  • athec_99 athec_99 Jul 21, 2014 8:07 PM Flag

    Really? Tell us what you've read about her? I'll bet you its anecdotal at best.

    Sentiment: Strong Sell

  • athec_99 by athec_99 Jul 21, 2014 8:53 AM Flag

    Just wondering, do they allow perp walks in PinK outfits, or does the perpetrator have to wear orange?

    Sentiment: Strong Sell

  • Steven Victor Convertible Promissory Note
    On October 1, 2013, the Company issued a $1,000,000 convertible promissory note to Dr. Steven Victor, the Company’s CEO, to convert $585,794 of accrued salary and $414,206 of personal loans due to Dr. Steven Victor (the “Victor Note”). The Victor Note is payable on demand and bears an annual 12% simple interest rate. The Victor Note is convertible into shares of the Company’s common stock at a price equal to the average five trading day closing bid price during the five days immediately prior to the conversion date multiplied by one and a half.
    On October 1, 2013, the Company was advised that the Victor Note was assigned to Redwood as part of Redwood Deal #5.

    Anna Rhodes Convertible Promissory Note
    On October 1, 2013, the Company issued a $389,711 convertible promissory note to Anna Rhodes, the Company’s Executive Vice President, to convert $229,464 of accrued salary and $160,247 of personal loans due to Anna Rhodes (the “Rhodes Note”). The Rhodes Note is payable on demand and bears an annual 12% simple interest rate. The Rhodes Note is convertible into shares of the Company’s common stock at a price equal to the average five trading day closing bid price during the five days immediately prior to the conversion date multiplied by one and a half.
    On October 1, 2013, the Company was advised that the Rhodes Note was assigned to Redwood as part of Redwood Deal #5.

    Sentiment: Strong Sell

  • athec_99 athec_99 Jul 17, 2014 8:08 PM Flag

    Sure... anything you say, Michele!! Talk about a team - Dr. B's medicine show is back, LOL

    Sentiment: Strong Sell

  • Reply to

    ATHEC_99 Really ??? your played out now

    by micheleajms Jul 1, 2014 12:39 PM
    athec_99 athec_99 Jul 16, 2014 2:12 PM Flag

    And that same something tells me that my disappointment with you is much, much less than the one you feel when you look at yourself in the mirror, lol.

    Sentiment: Strong Sell

  • Reply to

    ATHEC_99 Really ??? your played out now

    by micheleajms Jul 1, 2014 12:39 PM
    athec_99 athec_99 Jul 15, 2014 9:06 AM Flag

    Irritated and angered? That's all? I'm disappointed because I thought I DISGUSTED you.

    Sentiment: Strong Sell

  • Reply to

    ATHEC_99 Really ??? your played out now

    by micheleajms Jul 1, 2014 12:39 PM
    athec_99 athec_99 Jul 1, 2014 3:34 PM Flag

    More of your words: " didn't like you back then" and "you were a bit interesting in the beginning, why who etc."... I seriously doubt you and I have ever met, but go on, PLEASE, PRETTY PLEASE tell everyone "who I am"...what's the matter, 'cat' got your tongue? LMAO

    Sentiment: Strong Sell

  • The Freedom of Information Act (FOIA), 5 U.S.C. § 552, is a federal freedom of information law that allows for the full or partial disclosure of previously unreleased information and documents controlled by the United States government. The Act defines agency records subject to disclosure, outlines mandatory disclosure procedures and grants nine exemptions to the statute.
    A thing of beauty, this act is. It "clarifies, it cuts through, and captures the essence of" truth "in all its forms, for life, for money, for love, knowledge, has marked the upward surge of mankind". A harbinger of things to come.

    Sentiment: Strong Sell

  • Reply to

    ATHEC_99 Really ??? your played out now

    by micheleajms Jul 1, 2014 12:39 PM
    athec_99 athec_99 Jul 1, 2014 1:05 PM Flag

    Its your bunch that makes me laugh. The facility may be up to snuff for 'tissue processing', but not the rest of the FDA concerns. You think I'm all played out now? I haven't even started, so just keep right on dropping in - more 'laughs' sure to come! Ask Dr. LookGood about PRP's...and what was in your syringe, LMAO.
    Hey, these are your words: "some people do know who you are" - so, go ahead and tell everyone "who I am" then. You have my permission! Go on...ROFLMAO

    Sentiment: Strong Sell

  • Read it and weep, SVFC bagholders.

    IntelliCell’s adipose derived stem cells are human cells, tissues, or cellular and tissue-based products (HCT/Ps) as defined in 21 CFR 1271.3(d). However, this cellular product does not meet all of the criteria in 21 CFR 1271.10(a) and therefore is not regulated solely under section 361 of the Public Health Service Act (PHS Act) [42 U.S.C. 264] and the regulations in 21 CFR Part 1271. Specifically, your processing alters the relevant characteristics of the adipose tissue relating to the tissue’s utility for reconstruction, repair, or replacement. Therefore the processing would not meet the definition of minimal manipulation for structural tissue such as adipose tissue. As a result, the IntelliCell product does not meet the criterion in 21 CFR 1271.10(a)(1).

    In addition, some of the treatments you offer do not meet the definition of homologous use in 21 CFR 1271.3(c) (e.g., use of the IntelliCell product to treat osteoarthritis, gum recession). Also, records collected during the inspection indicate clinical uses of the IntelliCell product involving IV administration or administration (b)(4) of adipose-derived stem cells. These uses would not likely be considered homologous use. As a result, the IntelliCell product is a drug under section 201(g) of the Federal Food, Drug, and Cosmetic Act (the FD&C Act) [21 U.S.C. 321(g)] and a biological product as defined in section 351(i) of the PHS Act [42 U.S.C. 262(i)] that cannot qualify for regulation solely under section 361 of the PHS Act and 21 CFR Part 1271.

    Please be advised that in order to lawfully market such a biological drug product, a valid biologics license must be in effect [21 U.S.C. 355(a); 42 U.S.C. 262(a)]. Such licenses are issued only after a showing of safety and efficacy for the product’s intended use. While in the development stage, such products may be used in humans only if the sponsor has an investigational new drug (IND) application in effect as specified by F

    Sentiment: Strong Sell

  • athec_99 athec_99 Jul 1, 2014 8:49 AM Flag

    Brokeback surfy, the midnight cowboy. Lapdog and chicken excrement. Roberto Martinez. I'll be back in the city soon, chickenshit.

    Sentiment: Strong Sell

  • athec_99 athec_99 Jun 30, 2014 4:51 PM Flag

    Bingo! Some who knows what's going on and knows better not to rely on Dr. Botox's PR's which are just hype. And that scientific method and clinical data trumps a postings on facebook claiming a 'miracle' cure. Rock on, cadillacpuzzy.

    Sentiment: Strong Sell

  • athec_99 athec_99 Jun 30, 2014 4:25 PM Flag

    Wrong?? Who's been 'wrong' on this? I've had a strong sell sentiment ever since I started posting here, and I've been RIGHT ALL ALONG. And I will continue to be RIGHT, as long as Dr. LookGood is running this POS!!

    Sentiment: Strong Sell

  • athec_99 athec_99 Jun 30, 2014 10:30 AM Flag

    Hey Y_Razz, how are you're 'team building activities' going in iHub , LMAO? How much paper is the 'team' getting to pump this soon-to-be worthless stock? Just keep on sending the private messages - the 'team's true colors' are showing!

    Sentiment: Strong Sell

  • Reply to

    FDA Form 483, back to the 'science'

    by athec_99 Jun 27, 2014 10:45 AM
    athec_99 athec_99 Jun 28, 2014 11:53 AM Flag

    Angry and delusional - brokeback surfy is back. Back to the 'Denial' stage of Investor Grief? Or just bobbing up and down in the Doc's lap? Chin-platter, brokeback surfy - I didn't know the Doc had a lapdog named Roberto Martinez. LMAO

    Sentiment: Strong Sell

  • athec_99 athec_99 Jun 27, 2014 10:55 AM Flag

    LOL, Finance 101?
    How about Pump & Dump 101?
    Turn paper into cash, paper to cash, and more paper into cash while the shareholders/bagholders turn cash into paper, cash to paper and more cash into soon-to-be worthless paper!

    Sentiment: Strong Sell

  • There are no written procedures for production and process controls designed to assure that the DRUG PRODUCTS have the identity, strength, quality and purity they purport or are represented to possess.
    Specifically, a) during the Stromal Vascular Fraction manufacturing process (b)4 solution is added to the SVF process. Your procedure does not specify how this reagent is prepared and tested. b) Your firm manufactures a Stromal Vascular Fraction using (b)4. The stem cells are separated from adipose fat by centrifugation. However, there are no procedures in place and no documentation maintained showing validation and established working parameters for your Ultrasonic Processor.
    Notice the words 'DRUG PRODUCTS'.
    Interpretation: Dr. LookGood can't explain to the FDA what he has concocted in the flow cytometer machine from Miilipore and how he has concocted them. In other words, 'snake oil in a syringe'.

    Sentiment: Strong Sell

  • athec_99 athec_99 Jun 27, 2014 10:31 AM Flag

    NOBODY IS DESTROYING more of the shareholder value than Dr. Botox and his printing press, you idiot!MMA? Talk is cheap, brokeback. But I'll be back in the city soon enough...

    Sentiment: Strong Sell

  • athec_99 athec_99 Jun 27, 2014 10:21 AM Flag

    Jealous, brokeback?

    Sentiment: Strong Sell

SVFC
0.0015-0.0002(-11.76%)Jul 22 3:59 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.